MSB 3.21% $1.13 mesoblast limited

Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA, page-634

  1. 17,006 Posts.
    lightbulb Created with Sketch. 2410
    Funny you should say that because SI seems to have said a number of things that with hindsight seem to have completely misunderstood the FDA's position
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.